Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

The Index › Metabolic medicine › Whose sales may the drugs shrink?

Philip Morris

PM

Philip Morris sells cigarettes and smokeless nicotine products worldwide. We follow it because its sales depend on customers' habits, which health trends and health-driven policy may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
PM
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$193.12
close of 9 Nov 2026 · Massive and Yahoo agree
The day's range$192.26 – $199.11
9 Nov 2026 · both providers agree
52-week range$146.35 – $214.35
intraday low 4 Dec 2025 · intraday high 30 Oct 2026 · 251 sessions to 9 Nov 2026 · both providers agree
Market value$301.0 billion
the 9 Nov 2026 close × 1,558,655,629 shares outstanding on the 10-Q cover, as of 16 Oct 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

23 Oct 202610-Q · period ending 30 Sep 2026
21 Oct 20268-K · period ending 21 Oct 2026
18 Sep 20268-K · period ending 18 Sep 2026
8 Sep 20268-K · period ending 8 Sep 2026
8 Sep 20268-K · period ending 8 Sep 2026
24 Aug 20268-K · period ending 24 Aug 2026
24 Jul 202610-Q · period ending 30 Jun 2026
22 Jul 20268-K · period ending 22 Jul 2026
9 Jul 20268-K · period ending 6 Jul 2026
29 Jun 20268-K · period ending 29 Jun 2026
16 Jun 20268-K/A · period ending 18 May 2026
11 Jun 20268-K · period ending 11 Jun 2026
2 Jun 20268-K · period ending 2 Jun 2026
20 May 20268-K · period ending 18 May 2026
8 May 20268-K · period ending 6 May 2026
6 May 20268-K · period ending 6 May 2026
29 Apr 20268-K · period ending 27 Apr 2026
24 Apr 202610-Q · period ending 31 Mar 2026
22 Apr 20268-K · period ending 22 Apr 2026
13 Mar 20268-K · period ending 13 Mar 2026
5 Mar 20268-K · period ending 5 Mar 2026
18 Feb 20268-K · period ending 18 Feb 2026
18 Feb 20268-K · period ending 18 Feb 2026
6 Feb 202610-K · period ending 31 Dec 2025
6 Feb 20268-K · period ending 6 Feb 2026
15 Jan 20268-K · period ending 15 Jan 2026
12 Dec 20258-K · period ending 12 Dec 2025
11 Dec 20258-K · period ending 11 Dec 2025
2 Dec 20258-K · period ending 2 Dec 2025
17 Nov 20258-K · period ending 17 Nov 2025
4 Nov 20258-K · period ending 31 Oct 2025
29 Oct 20258-K · period ending 27 Oct 2025
24 Oct 202510-Q · period ending 30 Sep 2025
21 Oct 20258-K · period ending 21 Oct 2025
19 Sep 20258-K · period ending 19 Sep 2025
2 Sep 20258-K · period ending 2 Sep 2025
25 Jul 202510-Q · period ending 30 Jun 2025
22 Jul 20258-K · period ending 22 Jul 2025
24 Jun 20258-K · period ending 24 Jun 2025
13 Jun 20258-K · period ending 13 Jun 2025
6 Jun 20258-K · period ending 3 Jun 2025
3 Jun 20258-K · period ending 3 Jun 2025
9 May 20258-K · period ending 7 May 2025
7 May 20258-K · period ending 7 May 2025
30 Apr 20258-K · period ending 28 Apr 2025
24 Apr 202510-Q · period ending 31 Mar 2025
23 Apr 20258-K · period ending 23 Apr 2025
25 Mar 20258-K · period ending 25 Mar 2025
7 Mar 20258-K · period ending 6 Mar 2025
6 Mar 20258-K · period ending 6 Mar 2025
19 Feb 20258-K · period ending 19 Feb 2025
19 Feb 20258-K · period ending 19 Feb 2025
6 Feb 202510-K · period ending 31 Dec 2024
6 Feb 20258-K · period ending 6 Feb 2025
16 Jan 20258-K · period ending 16 Jan 2025
2 Jan 20258-K · period ending 31 Dec 2024
17 Dec 20248-K · period ending 17 Dec 2024
12 Dec 20248-K · period ending 12 Dec 2024
21 Nov 20248-K · period ending 21 Nov 2024

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-07-24 · period ending 2026-06-30

Read the filing

Machine-readable

/index/PM.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Whose sales may the drugs shrink?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-07-24 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Philip Morris. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-07-24
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)